Hippocrates Health Institute, a wellness retreat in West Palm Beach, Florida, has drawn sustained criticism for promoting raw vegan diets, wheatgrass juice, and other lifestyle-based protocols as treatments for serious diseases, including cancer. The institute’s controversies range from the scientific basis of its dietary claims to high-profile cases involving children who left conventional cancer treatment to follow its programs, and regulatory actions against its leadership for practicing medicine without a license. The friction sits at the intersection of patient autonomy, unproven health claims, and the real-world consequences of choosing unvalidated therapies over evidence-based care.
What Hippocrates Health Institute Promotes
The institute traces its roots to Ann Wigmore, who in the 1950s began advocating raw and living foods, particularly wheatgrass juice, as healing therapies. The organization eventually relocated from Boston to South Florida and came under the direction of Brian Clement, who has used the title “Dr.” based on a nutrition-related credential rather than a medical degree. The core program centers on a raw vegan diet heavy in sprouts, fermented foods, and fresh-pressed wheatgrass juice, combined with practices like colon hydrotherapy and supplement regimens. Participants typically attend multi-week residential stays.
The institute’s promotional materials have historically framed these dietary and lifestyle interventions not merely as wellness support but as therapeutic interventions for cancer, diabetes, heart disease, and other serious conditions. That framing is where the controversy sharpens: it positions food-based protocols as viable replacements for, rather than complements to, conventional medical treatment. This distinction matters enormously when the disease in question is treatable with established therapies and the patient forgoes them.
What Science Actually Says About Wheatgrass
Wheatgrass juice is the institute’s flagship product, and it has been studied to some extent in laboratory settings. A 2024 review of wheatgrass and colorectal cancer found that while the juice has been attributed anti-inflammatory, antioxidant, and anticancer properties, evidence remains limited and the topic has been “minimally investigated.”1PubMed Central. The Role of Wheatgrass in Colorectal Cancer: A Review of the Current Evidence A separate lab study did observe that an aqueous wheatgrass extract inhibited roughly 40% of oral cancer cells at high concentrations in a petri dish over 24 hours, but that kind of cell-culture result is several giant steps removed from clinical evidence in humans.2PubMed Central. Wheatgrass: Green Blood can Help to Fight Cancer
A 2025 narrative review acknowledged that wheatgrass juice has “shown promise as an adjunct in cancer treatment, cardiovascular health, and gastrointestinal disorders,” but explicitly cautioned that most of the supporting evidence comes from limited studies and that more rigorous scientific validation is needed.3PubMed Central. Therapeutic Potential of Wheatgrass Juice: A Comprehensive Narrative Review In plain terms, wheatgrass juice is not established medicine. There are no randomized clinical trials showing it treats or cures any cancer in living people. Killing cells in a dish is something bleach can also do; the bar for calling something a treatment is vastly higher.
This gap between laboratory curiosity and clinical proof is central to the criticism of HHI. Presenting preliminary cell-study results to patients as though they constitute evidence of a cure crosses a line that concerns both oncologists and regulators.
Cases Involving Children
The controversy reached its most painful point in 2014 and 2015, when two Indigenous Canadian girls with treatable forms of leukemia left chemotherapy programs and traveled to HHI. Makayla Sault, an 11-year-old from the Mississaugas of the New Credit First Nation, stopped her chemotherapy after experiencing severe side effects and, with her family’s support, attended HHI’s program instead. She died in early 2015. Another girl, whose identity was protected under Canadian law, was also removed from chemotherapy by her family and reportedly attended the institute. That case became a legal battle in Ontario, with courts ultimately respecting the family’s decision under Indigenous rights frameworks, though the child’s cancer later relapsed.
These cases ignited a fierce public debate about parental autonomy, Indigenous sovereignty, medical ethics, and the role of institutions like HHI in encouraging families to abandon proven therapies. Brian Clement was reported to have told families that the institute’s program had a high success rate with cancer, a claim that could not be independently verified and which drew sharp condemnation from pediatric oncologists.
Pediatric treatment refusal is not unique to HHI. A qualitative study of cancer treatment refusal in the United States cataloged dozens of distinct cases and identified seven categories of refusal, ranging from outright refusal of all therapy to negotiation for inclusion of complementary and alternative approaches alongside standard treatment. Each case followed a unique and complex path, often involving multiple stages of conflict between families and medical teams.4PubMed Central. Landscape of pediatric cancer treatment refusal and abandonment in the US: A qualitative study But HHI’s active marketing of its programs to families already skeptical of conventional medicine placed it at the center of these cases in a way that drew particular scrutiny.
What Happens When Patients Choose Alternative Medicine Instead of Standard Cancer Treatment
The broader research on what happens when cancer patients choose alternative medicine in place of conventional care is sobering. A study published in the Journal of the National Cancer Institute compared outcomes for patients who used alternative medicine as their sole treatment against matched patients who received conventional therapy. Those who used only alternative medicine had roughly two and a half times the overall risk of death. For breast cancer specifically, the risk was more than five times higher. For colorectal cancer, it was about four and a half times higher.5JNCI: Journal of the National Cancer Institute. Use of Alternative Medicine for Cancer and Its Impact on Survival
A follow-up study in JAMA Oncology added an important nuance. It found that patients who used complementary medicine alongside conventional treatment had lower five-year survival than patients who used no complementary approaches, but this gap disappeared once the analysis accounted for whether patients also delayed or refused conventional therapies. In other words, complementary medicine itself was not the direct cause of worse outcomes. The problem was that people who gravitated toward it were also more likely to refuse or delay surgery, chemotherapy, or radiation.6PubMed Central. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers
This distinction matters for understanding the HHI controversy. The danger is not that someone drinks wheatgrass juice while also getting chemotherapy. The danger is that institutions positioning dietary protocols as cancer treatments can lead patients to skip the treatments that actually work. When researchers identified the mechanism linking complementary medicine to worse survival, it was treatment refusal and delay, not the complementary therapies themselves. HHI’s model, which frames its programs as an alternative rather than a supplement, slots into the riskier end of that spectrum.
The Communication Breakdown Between Patients and Oncologists
Researchers who have studied what happens in clinical conversations when patients decline conventional treatment in favor of alternative approaches have found a striking disconnect. A qualitative study involving cancer patients who had declined some or all conventional treatment, along with oncologists and palliative care physicians, found that physicians focused on medical reasoning while patients expressed complex personal values. When patients brought up alternative medicine, communication often deteriorated further, and the resulting power struggles pushed both sides toward more extreme and inflexible positions.7Oxford Academic (The Oncologist). Communication About Complementary and Alternative Medicine When Patients Decline Conventional Cancer Treatment: Patients’ and Physicians’ Experiences
This dynamic helps explain how places like HHI gain a foothold. Patients who feel dismissed or steamrolled by their oncologists are more receptive to institutions that validate their concerns, even when the alternative lacks evidence. The institute’s residential model, where participants spend weeks surrounded by like-minded people in a supportive environment, can feel more affirming than a rushed oncology appointment. That emotional reality does not make the institute’s health claims true, but it does illuminate why patients make the choices they do, and why simply telling people to “trust the science” often fails to change behavior.
Costs and Financial Pressures
HHI’s programs are not cheap. Multi-week stays have been reported to cost thousands of dollars, and the financial burden on patients seeking alternative cancer treatment more broadly is well-documented. A content analysis of crowdfunding campaigns for alternative cancer treatments at clinics in Tijuana, Mexico, found that patients reported treatment costs ranging from $11,000 to $100,000, with a median of $45,000.8PubMed Central. Crowdfunding for Complementary and Alternative Cancer Treatments in Tijuana, Mexico: Content Analysis While that study focused on Mexican clinics rather than HHI specifically, the financial profile is similar across the alternative cancer treatment industry: patients pay large sums out of pocket for unproven therapies, often after exhausting savings or turning to online fundraising.
The financial dimension adds an ethical layer to the controversy. Patients are not just risking their health by choosing unproven treatments; they are spending substantial money on interventions that have no demonstrated efficacy for the diseases they are hoping to treat. When an institution charges premium prices for programs built around wheatgrass juice and raw food, and its clients include people with curable cancers, the financial extraction becomes part of the harm.
Regulatory and Legal Gaps
Florida’s Department of Health investigated Brian Clement and issued a cease-and-desist order, citing him for practicing medicine without a license. Clement is not a licensed physician, and the state took the position that the health claims and recommendations he was making to patients constituted the unlicensed practice of medicine. However, enforcement in the alternative wellness space is notoriously difficult. HHI has continued to operate, in part because wellness retreats occupy a regulatory gray area between food service, hospitality, and healthcare.
The challenge is not unique to Florida or to HHI. Research on legal frameworks governing traditional and alternative medicine practitioners has found that high public demand for these services is often not matched by adequate oversight. Many practitioners operate without official licenses, ethical standards, or meaningful state supervision, and even when legislation formally recognizes alternative health services, implementation tends to be weak due to fragmented oversight and a lack of specific accountability mechanisms.9Soepra Jurnal Hukum Kesehatan. Legal Gaps in the Supervision and Practice of Traditional and Non-Medical Alternative Medicine The result is an environment where institutions can make sweeping health claims with relatively little regulatory consequence, at least until a high-profile case forces attention.
How Integrative Oncology Differs
One of the most important distinctions that gets lost in the HHI controversy is the difference between alternative medicine and integrative oncology. Integrative oncology is a recognized, evidence-informed field that uses mind-body practices, natural products, and lifestyle modifications alongside conventional cancer treatments, not as replacements for them. It prioritizes safety and the best available evidence.10PubMed Central. Putting Integrative Oncology Into Practice: Concepts and Approaches Major cancer centers around the world now offer integrative programs that include things like acupuncture for chemotherapy-induced nausea, meditation for anxiety, and nutritional counseling. These programs operate under medical supervision and are designed to complement, not undermine, standard treatment.
A formal definition published in the JNCI Monographs stressed that not everything labeled “integrative oncology” belongs to the field. The authors warned that vulnerable cancer patients are still offered methods that are dangerous, lack scientific evidence, and carry high out-of-pocket costs.11JNCI Monographs. A Comprehensive Definition for Integrative Oncology HHI’s approach, which positions its dietary programs as a therapeutic system capable of addressing cancer, falls outside what the integrative oncology community considers legitimate. The problem is that patients often cannot tell the difference between a hospital-based integrative oncology program and a for-profit wellness center making unsupported claims.
Food Safety Concerns with Wheatgrass Juice
Beyond the question of whether wheatgrass juice treats disease, there are more basic safety issues with the product itself. Wheatgrass juice is a low-acid liquid, which makes it a favorable environment for bacterial growth. In the United States, wheatgrass juice is often distributed frozen specifically to prevent the growth of Clostridium botulinum, a potentially deadly pathogen whose spores are widespread in nature. Other bacteria implicated in juice-related disease outbreaks include E. coli (particularly Shiga toxin-producing strains like O157:H7) and Salmonella. The low infectious dose and severity of STEC infections make this a meaningful concern for any facility serving fresh wheatgrass juice daily.
For a healthy adult, the occasional shot of wheatgrass juice from a reputable source is unlikely to pose a serious risk. But HHI’s clientele includes people who are already ill, sometimes severely so. Cancer patients, especially those who have undergone chemotherapy that suppresses their immune systems, are more vulnerable to foodborne infections. Serving fresh-pressed, unpasteurized wheatgrass juice to an immunocompromised population raises safety questions that go beyond the juice’s lack of therapeutic value.
The Misinformation Pipeline
HHI does not operate in a vacuum. It exists within a broader ecosystem of cancer treatment misinformation that reaches patients through social media, wellness influencers, and word of mouth. Research has documented that cancer patients are regularly exposed to misinformation and unsolicited advice about alternative treatments, and that this exposure can influence treatment decisions.12PubMed Central. Exposure and Reactions to Cancer Treatment Misinformation and Advice: Survey Study Testimonials from former HHI participants circulate online, and the institute’s programs benefit from a narrative that positions conventional medicine as harmful and natural approaches as suppressed truths.
This pipeline is self-reinforcing. A patient who already distrusts conventional medicine encounters testimonials and social media content from alternative treatment centers, which confirms their suspicions and provides a seemingly legitimate destination for their care. Institutions like HHI serve as the end point of a funnel that begins with widely shared misinformation. Addressing the controversy around any single center without addressing the broader information environment is like treating a symptom while ignoring the disease, though in this case, the irony of that metaphor is hard to miss.
Cross-Border Treatment Seeking
The phenomenon of patients traveling across borders for alternative cancer care extends well beyond HHI. A survey of Mexican oncologists found that the vast majority had interacted with U.S.-based patients who traveled to Mexico for treatment. While most were seeking conventional therapies like surgery and chemotherapy, often because they lacked adequate health insurance, a smaller group sought non-approved therapies including homeopathic and alternative treatments.13PubMed Central. Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists HHI’s Florida location makes it a domestic version of the same dynamic: patients traveling to a specific facility because they believe it offers something their local medical system cannot or will not provide.
The financial motivations differ, though. Patients going to Mexico often cite insurance gaps and affordability. Patients going to HHI tend to be motivated more by ideology: a belief in natural healing, distrust of pharmaceutical companies, or a desire for personal agency over their treatment. Both groups are vulnerable, but in different ways. The HHI patient who can afford a multi-week retreat is making a choice shaped by belief systems that the institute actively cultivates, while the uninsured patient crossing into Mexico may simply be trying to get any treatment they can access. Understanding these different motivations matters for anyone trying to figure out how to reduce the harm caused by unproven treatment centers.